First report 1h ago•Last update 16m ago
US Drug Agency Approves Pancreatic Cancer Treatment
The US drug agency has approved daraxonrasib, a breakthrough treatment for pancreatic cancer, hailed as a game-changer for one of the deadliest cancers.
iWitness comments
No comments yet — be the first to weigh in.